1. Home
  2. IMNM vs AMR Comparison

IMNM vs AMR Comparison

Compare IMNM & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.35

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Alpha Metallurgical Resources Inc.

AMR

Alpha Metallurgical Resources Inc.

HOLD

Current Price

$165.77

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
AMR
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IMNM
AMR
Price
$19.35
$165.77
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$32.80
$181.50
AVG Volume (30 Days)
1.3M
245.6K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
$2,129,481,000.00
Revenue This Year
N/A
$15.05
Revenue Next Year
$1,127.34
$14.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.96
$104.42
52 Week High
$27.65
$253.82

Technical Indicators

Market Signals
Indicator
IMNM
AMR
Relative Strength Index (RSI) 46.93 36.63
Support Level $19.28 $151.08
Resistance Level $23.00 $182.72
Average True Range (ATR) 0.84 10.03
MACD 0.21 -4.20
Stochastic Oscillator 49.16 11.03

Price Performance

Historical Comparison
IMNM
AMR

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

Share on Social Networks: